The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non-small cell lung cancer (NSCLC).
 
Dwight Hall Owen
No Relationships to Disclose
 
Paul A. Bunn
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche; Lilly; Merck; Merck Serono; Merrimack; Novartis; Pfizer; Puma Biotechnology
 
Bruce E. Johnson
Stock and Other Ownership Interests - KEW
Honoraria - Chugai Pharma; Merck
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Clovis Oncology; Genentech; KEW; Lilly; Merck; Novartis; Transgene
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute
Expert Testimony - Genentech
 
David J. Kwiatkowski
No Relationships to Disclose
 
Mark G. Kris
Consulting or Advisory Role - ARIAD; AstraZeneca; Genentech/Roche
Research Funding - Genentech/Roche (Inst); Puma Biotechnology (Inst)
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Ariad; AstraZeneca; Asuragen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; GE Healthcare; Genecentric; Genentech/Roche; GlaxoSmithKline; HTG Molecular Diagnostics; Lilly; Lilly; Pfizer; Synta
Speakers' Bureau - Boehringer Ingelheim; Medscape; Pfizer
Research Funding - Bayer; Genentech; HTG Molecular Diagnostics; Jounce Therapeutics; Merck; Myriad Genetics; OncoPlex Diagnostics
 
Mayank Gandhi
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
See Phan
Employment - Genentech
 
David S. Shames
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Katja Schulze
Employment - Genentech
 
Wei Yu
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche/Genentech
 
Dara Aisner
Honoraria - AstraZeneca; Clovis Oncology
Consulting or Advisory Role - Inivata
Research Funding - Genentech/Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for pneumatic cell collection device
Travel, Accommodations, Expenses - SeraCare
 
Jamie E. Chaft
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Edward B. Garon
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Jay M Lee
No Relationships to Disclose
 
John D. Minna
Patents, Royalties, Other Intellectual Property - NIH/NCI; UTSW Royalties
 
Valerie W. Rusch
Research Funding - Genelux (Inst)
Travel, Accommodations, Expenses - da Vinci Surgery
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Boehringer Ingelheim; Euclises; Nektar
Research Funding - Adaptimmune (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Xcovery (Inst)
 
Antoinette J. Wozniak
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Genentech/Roche; Lilly; Novartis
Research Funding - Astex Pharmaceuticals; Boehringer Ingelheim
 
David P. Carbone
Consulting or Advisory Role - Genentech